MARKET

STAA

STAA

Staar Surg
NASDAQ
29.22
+0.30
+1.04%
After Hours: 28.67 -0.55 -1.88% 16:47 06/17 EDT
OPEN
28.83
PREV CLOSE
28.92
HIGH
29.61
LOW
28.52
VOLUME
484.30K
TURNOVER
--
52 WEEK HIGH
35.87
52 WEEK LOW
15.59
MARKET CAP
1.45B
P/E (TTM)
-68.0801
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STAA last week (0608-0612)?
Weekly Report · 2d ago
STAAR Surgical Raises Pay for Interim Co-CEO Andrews
TipRanks · 06/09 21:04
STAAR Surgical lifts interim co-CEO CFO Deborah Andrews’ base salary to $575,000
PUBT · 06/09 20:02
Weekly Report: what happened at STAA last week (0601-0605)?
Weekly Report · 06/08 10:30
Weekly Report: what happened at STAA last week (0525-0529)?
Weekly Report · 06/01 10:36
Staar Surgical Price Target Maintained With a $40.00/Share by Wedbush
Dow Jones · 05/29 13:56
Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target
Benzinga · 05/29 13:46
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Cogent Biosciences (COGT) and GlaxoSmithKline (GSK)
TipRanks · 05/29 13:40
More
About STAA
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company,s newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also markets and sells an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company's principal products are ICLs used in refractive surgery, including its EVO family of lenses.

Webull offers STAAR Surgical Co stock information, including NASDAQ: STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.